AAAAAA
Results:
1-17
|
Results: 17
Authors:
SPINLER SA
NAWARSKAS JJ
FOOTE EF
SABAPATHI D
CONNORS JE
MARCHLINSKI FE
Citation: Sa. Spinler et al., CLINICAL PRESENTATION AND ANALYSIS OF RISK-FACTORS FOR INFECTIOUS COMPLICATIONS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATIONS AT A UNIVERSITY MEDICAL-CENTER, Clinical infectious diseases, 26(5), 1998, pp. 1111-1116
Authors:
FOOTE EF
DAHL NV
Citation: Ef. Foote et Nv. Dahl, MORE DRUG IDIOSYNCRASIES IN END-STAGE RENAL-DISEASE, Seminars in dialysis, 11(3), 1998, pp. 167-174
Authors:
FOOTE EF
DREITLEIN WB
STEWARD CA
KAPOIAN T
WALKER JA
SHERMAN RA
Citation: Ef. Foote et al., PHARMACOKINETICS OF VANCOMYCIN WHEN ADMINISTERED DURING HIGH-FLUX HEMODIALYSIS, Clinical nephrology, 50(1), 1998, pp. 51-55
Authors:
FOOTE EF
HALSTENSON CE
Citation: Ef. Foote et Ce. Halstenson, EFFECTS OF PROBENECID AND CIMETIDINE ON RENAL DISPOSITION OF OFLOXACIN IN RATS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 456-458
Authors:
FOOTE EF
AVERY L
Citation: Ef. Foote et L. Avery, USE OF CLINDAMYCIN FOR PERITONITIS IN PD PATIENTS, Seminars in dialysis, 10(1), 1997, pp. 57-58
Authors:
DREITLEIN WB
FOOTE EF
KAPOIAN T
STEWARD CA
WALKER JA
SHERMAN RA
Citation: Wb. Dreitlein et al., PHARMACOKINETICS (PK) OF VANCOMYCIN WHEN ADMINISTERED DURING HIGH-FLUX HEMODIALYSIS (HFHD), Journal of the American Society of Nephrology, 7(9), 1996, pp. 983-983
Authors:
BRADLEY ME
FOOTE EF
LEE EN
MERKLE L
Citation: Me. Bradley et al., SERTRALINE-ASSOCIATED SYNDROME OF INAPPROPRIATE ANTIDIURETIC-HORMONE - CASE-REPORT AND REVIEW OF THE LITERATURE, Pharmacotherapy, 16(4), 1996, pp. 680-683
Authors:
FOOTE EF
Citation: Ef. Foote, PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY, American journal of health-system pharmacy, 52(16), 1995, pp. 1781-1792
Authors:
SEYSS C
FOOTE EF
Citation: C. Seyss et Ef. Foote, CALCIUM-CHANNEL BLOCKERS FOR PROPHYLAXIS OF RADIOCONTRAST-ASSOCIATED NEPHROTOXICITY, The Annals of pharmacotherapy, 29(2), 1995, pp. 187-188
Authors:
MENZ JM
FOOTE EF
Citation: Jm. Menz et Ef. Foote, ACCURACY OF VANCOMYCIN ASSAYS IN DIALYSIS PATIENTS, Seminars in dialysis, 8(5), 1995, pp. 320-321
Authors:
FOOTE EF
Citation: Ef. Foote, AVAILABILITY OF QUININE FOR MUSCLE CRAMPS IN DIALYSIS PATIENTS, Seminars in dialysis, 8(4), 1995, pp. 244-245
Authors:
FOOTE EF
LOOK ZM
GILES P
KEANE WF
HALSTENSON CE
Citation: Ef. Foote et al., THE PHARMACOKINETICS OF AMINOGUANIDINE IN END-STAGE RENAL-DISEASE PATIENTS ON HEMODIALYSIS, American journal of kidney diseases, 25(3), 1995, pp. 420-425
Authors:
FOOTE EF
LEE DR
KARIM A
KEANE WF
HALSTENSON CE
Citation: Ef. Foote et al., DISPOSITION OF MISOPROSTOL AND ITS ACTIVE METABOLITE IN PATIENTS WITHNORMAL AND IMPAIRED RENAL-FUNCTION, Journal of clinical pharmacology, 35(4), 1995, pp. 384-389
Authors:
FOOTE EF
Citation: Ef. Foote, SAFETY OF PROPOXYPHENE IN DIALYSIS PATIENTS, Seminars in dialysis, 7(3), 1994, pp. 218-219
Authors:
FOOTE EF
Citation: Ef. Foote, RISK OF HIGH-DOSE ERYTHROMYCIN IN END-STAGE RENAL-DISEASE, Seminars in dialysis, 7(2), 1994, pp. 147-148
Authors:
FOOTE EF
HALSTENSON CE
Citation: Ef. Foote et Ce. Halstenson, NEW THERAPEUTIC AGENTS IN THE MANAGEMENT OF HYPERTENSION - ANGIOTENSIN II-RECEPTOR ANTAGONISTS AND RENIN INHIBITORS, The Annals of pharmacotherapy, 27(12), 1993, pp. 1495-1503
Authors:
STPETER JV
BRADY ME
FOOTE EF
DANDEKAR KA
SMALDONE L
PYKKONEN JL
KEANE WF
HALSTENSON CE
Citation: Jv. Stpeter et al., THE DISPOSITION AND PROTEIN-BINDING OF BATANOPRIDE AND ITS METABOLITES IN SUBJECTS WITH RENAL IMPAIRMENT, European Journal of Clinical Pharmacology, 45(1), 1993, pp. 59-63
Risultati:
1-17
|